Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring
Open Access
- 31 December 2020
- Vol. 10 (1), 48
- https://doi.org/10.3390/cells10010048
Abstract
Head and neck cancer (HNC), the seventh most common form of cancer worldwide, is a group of epithelial malignancies affecting sites in the upper aerodigestive tract. The 5-year overall survival for patients with HNC has stayed around 40–50% for decades, with mortality being attributable mainly to late diagnosis and recurrence. Recently, non-coding RNAs, including tRNA halves, YRNA fragments, microRNAs (miRNAs), and long non-coding RNAs (lncRNAs), have been identified in the blood and saliva of patients diagnosed with HNC. These observations have recently fueled the study of their potential use in early detection, diagnosis, and risk assessment. The present review focuses on recent insights and the potential impact that circulating non-coding RNA evaluation may have on clinical decision-making in the management of HNC.This publication has 85 references indexed in Scilit:
- LNCipedia: a database for annotated human lncRNA transcript sequences and structuresNucleic Acids Research, 2012
- Landscape of transcription in human cellsNature, 2012
- RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesisNature Structural & Molecular Biology, 2012
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteinsNature, 2011
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasmaProceedings of the National Academy of Sciences of the United States of America, 2011
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerThe New England Journal of Medicine, 2010
- Noncoding human Y RNAs are overexpressed in tumours and required for cell proliferationBritish Journal of Cancer, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature, 2007
- MicroRNA expression profiles classify human cancersNature, 2005